findmyKOL
Clinical trialNCT02527213WithdrawnPhase 3Interventional

Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy

SponsorAmerican Regent, Inc.Enrollment0Calcific Uremic ArteriolopathyCalciphylaxis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Nephrology Consultants

    Huntsville, Alabama, United States

  • Nephrology Association of Northern Indiana

    Fort Wayne, Indiana, United States

  • A.A. Northeast Clinical Research Center

    Bethlehem, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jan 2015
Primary completion
29 Aug 2016
Completion
29 Aug 2016
Last update posted
7 May 2025
Registered enrollment
0
Registry id
NCT02527213

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.